Adial Pharmaceuticals Stock Market Value
| ADIL Stock | USD 0.99 0.03 2.94% |
| Symbol | Adial |
Adial Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.88) | Return On Assets (1.04) | Return On Equity (3.21) |
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Adial Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Adial Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Adial Pharmaceuticals.
| 10/15/2024 |
| 11/14/2024 |
If you would invest 0.00 in Adial Pharmaceuticals on October 15, 2024 and sell it all today you would earn a total of 0.00 from holding Adial Pharmaceuticals or generate 0.0% return on investment in Adial Pharmaceuticals over 30 days. Adial Pharmaceuticals is related to or competes with Transcode Therapeutics, Aditxt, Reviva Pharmaceuticals, Avenue Therapeutics, Aileron Therapeutics, Bio Path, and Benitec Biopharma. Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for ... More
Adial Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Adial Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Adial Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.32 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 17.89 | |||
| Value At Risk | (5.45) | |||
| Potential Upside | 8.42 |
Adial Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adial Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Adial Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Adial Pharmaceuticals historical prices to predict the future Adial Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0274 | |||
| Jensen Alpha | 0.0702 | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 1.35 |
Adial Pharmaceuticals Backtested Returns
As of now, Adial Stock is slightly risky. Adial Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0263, which signifies that the company had a 0.0263% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Adial Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Adial Pharmaceuticals' Risk Adjusted Performance of 0.0274, downside deviation of 3.32, and Mean Deviation of 2.36 to double-check if the risk estimate we provide is consistent with the expected return of 0.0928%. Adial Pharmaceuticals has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0581, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Adial Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Adial Pharmaceuticals is expected to be smaller as well. Adial Pharmaceuticals right now shows a risk of 3.53%. Please confirm Adial Pharmaceuticals jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to decide if Adial Pharmaceuticals will be following its price patterns.
Auto-correlation | 0.35 |
Below average predictability
Adial Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Adial Pharmaceuticals time series from 15th of October 2024 to 30th of October 2024 and 30th of October 2024 to 14th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Adial Pharmaceuticals price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Adial Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Adial Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Adial Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Adial Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Adial Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Adial Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Adial Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Adial Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Adial Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Adial Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Adial Pharmaceuticals Lagged Returns
When evaluating Adial Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Adial Pharmaceuticals stock have on its future price. Adial Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Adial Pharmaceuticals autocorrelation shows the relationship between Adial Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Adial Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Adial Pharmaceuticals Correlation, Adial Pharmaceuticals Volatility and Adial Pharmaceuticals Alpha and Beta module to complement your research on Adial Pharmaceuticals. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Adial Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.